CYP19A1 and epilepsy: Specifically, with regard to men with epilepsy, current clinical data suggests that aromatase inhibitors could possibly enhance patient responses to antiepileptic treatments and that compounds capable of inhibiting aromatase should be analyzed for potential use in antiepileptic treatments [7].